Global Analysis of Psoriasis Market Outlook and Forecasts to 2020 - iCrowdNewswire

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

Europe ( XML Feed )
United States ( XML Feed )

Jul 29, 2017 3:10 PM ET

Global Analysis of Psoriasis Market Outlook and Forecasts to 2020

iCrowdNewswire - Jul 29, 2017

Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It is an autoimmune disease and may be triggered by smoking, alcohol consumption, cold or dry weather and stress. Complete report on Psoriasis industry spread across 45 pages with providing 4 company profiles, 6 tables and 28 charts is now available at


In the wake of lesser treatment options and costly therapies, psoriasis remains as an under treated disease. Psoriasis treatment can be divided into three main groups: topical treatment, light therapy, and systemic medication based on the severity of the disease. The typical treatment options include TNF inhibitors and IL inhibitors. However, various therapies and drugs are in the pipeline and it is expected that treatment options will improve over time with higher efficacy and lower costs.


The global market for psoriasis has been increasing consistently over the last few years. The major factors contributing to the growth of the global psoriasis market are increasing smoking and alcohol consumption trends globally. Surging smoking population, increased spending on medicines, increasing sales of prescription drugs and escalating health care expenditure are the key growth drivers of the market. However, growth of the market is hindered by extensive drug development and approval process and side-effects associated with the existing medication for psoriasis.


Order a copy of this “Global Psoriasis Market” research report at USD 800 (Single User License)


Various treatment methods are readily used to control psoriasis in the US, such as TNFs, systemics and topicals. With relatively higher prevalence rates in the US, several companies are trying to grab larger market shares with their new and innovative drugs. Plaque psoriasis is a common form of this disease in the US with increasing prevalence each year.


The report “Global Psoriasis Market” analyzes the development of this market, with focus on the US treatment market. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson and Johnson, Abbvie inc., Amgen Inc. and Novartis are being profiled along with their key financials and strategies for growth.


Browse All Latest Reports on Pharmaceuticals Market at

Contact Information:

Ritesh Tiwari
Tel: + 1 888 391 5441
E-mail: [email protected]

View Related News >